GlassScriptPhysician profile
Jancy Cherian
NPI 1639551963
$728.35
in general payments reported to CMS, 2019-2025
16 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.17 · 2022: $84.14 · 2023: $22.92 · 2024: $75.45 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $129.46 | 2024-2025 | Airsupra, Farxiga |
| Exact Sciences Corporation | $91.76 | 2023-2025 | Cologuard Collection Kit |
| Mannkind Corporation | $84.14 | 2022 | |
| Lilly USA, LLC | $67.09 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $56.66 | 2025 | Ozempic |
| Esperion Therapeutics, INC. | $40.97 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $37.80 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.90 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $32.05 | 2025 | Shingrix, Arexvy |
| Amgen INC. | $31.81 | 2025 | Repatha, Otezla |
| Gilead Sciences, INC. | $26.17 | 2025 | |
| Sanofi-Aventis U.S. LLC | $23.50 | 2025 | |
| Xeris Pharmaceuticals, INC. | $20.97 | 2025 | Gvoke Hypopen |
| Sumitomo Pharma America, INC. | $19.25 | 2025 | Gemtesa |
| Radius Health, INC. | $16.52 | 2025 | Tymlos |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jancy Cherian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.